Unknown NA INTERVENTIONAL 2-arm NCT02771756

The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Randomized, Self Controlled Study on the Effect of Oral Supplement of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Sponsor: Chinese Academy of Medical Sciences

Conditions Breast Cancer Lung Cancer

Interventions chemotherapy nutrition education zhen qishen capsule and Oral Supplement of Yuyikang zhen qishen capsule placebo and Oral Supplement of Yuyikang placebo

Updated 7 times since 2017 Last updated: May 12, 2016 Started: May 31, 2015 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02771756, this NA trial focuses on Breast Cancer and Lung Cancer and remains ongoing. Sponsored by Chinese Academy of Medical Sciences, it has been updated 7 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status NA
Dec 2022 — Oct 2023 [monthly]

Unknown Status NA
Jan 2021 — Dec 2022 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese Academy of Medical Sciences

Data source: ChineseAMS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China